The incidence of cervical cancer, as well as mortality rates from the disease, has decreased over the past 30 years because of widespread screening with cervical cytology. The American College of Obstetricians and Gynecologists (ACOG) recently published a clinical management guideline on cervical cytology screening.
Cancer
Prostate-Cancer Screening Guidelines
The rationale for screening is that early detection and treatment of asymptomatic cancers could extend life, as compared with treatment at the time of clinical diagnosis. The introduction of prostate-specific antigen (PSA) testing has nearly doubled the lifetime risk of receiving a diagnosis of prostate cancer.
Guidelines for the Use of Erythropoietic Proteins in Anaemic Patients with Cancer
Anaemia is a frequent finding in cancer patients and should be carefully assessed. Additional causes of anaemia such as iron deficiency, bleeding, nutritional defects or haemolysis should be corrected prior to erythropoietic protein therapy. The following recommendations are related to adult cancer patients with solid tumours or haematological malignancies:
Indications and Contraindications Radioiodine Treatment of Differentiated Thyroid Cancer (DTC)
Differentiated thyroid cancer (DTC) is defined as a carcinoma deriving from the follicular epithelium and retaining basic biological characteristics of healthy thyroid tissue, including expression of the sodium iodide symporter (NIS), the key cellular feature for specific iodine uptake.
Staging of Prostate Cancer
The Tumor-Node-Metastasis (TNM) System
MASCC Index Score for Identifying Low-Risk Febrile Neutropenic Cancer Patients
Scoring system for risk of complications among febrile neutropenic patients, based on the Multinational Association for Supportive Care in Cancer (MASCC) predictive model.
Tumor, Node, Metastasis International Staging System for Lung Cancer
The Tumor, Node, Metastasis (TNM) staging system for lung cancer is an internationally accepted system used to characterize the extent of disease. The TNM system combines features of the tumor into disease stage groups that correlate with survival and are linked to recommendations for treatment.
Revised Criteria for Hereditary Non-Polyposis Colorectal Cancer (Lynch Syndrome)
Amsterdam Criteria (1991)
Three or more relatives with colorectal cancer, plus all of the following:
-
One affected patient should be a first-degree relative of the other two;
-
Colorectal cancer should involve at least two generations;
-
At least one case of colorectal cancer should have been diagnosed before the age of 50 years.